As of December 26, 2025, Royal Caribbean Group (NYSE: RCL) stands as a titan of the global tourism industry, having navigated one of the most tumultuous periods in maritime history to emerge stronger, more efficient, and more profitable than ever. Once viewed through the lens of pandemic recovery, RCL is now defined by its aggressive [...]
As 2025 draws to a close, Berkshire Hathaway (NYSE: BRK.A, BRK.B) finds itself at the most significant crossroads in its sixty-year history. Once defined by its "buy and hold forever" mantra, the Omaha-based conglomerate has spent the last 24 months executing a historic tactical retreat from its most celebrated equity positions. With Warren Buffett’s formal [...]
Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) reported Q3 CY2025 results topping the market’s revenue expectations, but sales fell by 5.7% year on year to $14.54 million. Its non-GAAP loss of $0.38 per share was 9.6% below analysts’ consensus estimates.
Shares of blockchain infrastructure company Coinbase (NASDAQ:COIN) jumped 4.3% in the afternoon session after its CEO unveiled a 2026 'Everything Exchange' plan to integrate stocks, prediction markets, and other assets into a single global app.
Shares of semiconductor packaging and testing company Amkor Technology (NASDAQ:AMKR) jumped 5.6% in the afternoon session after the stock rallied alongside its peers as the Philadelphia Semiconductor Index surged.
Shares of computer processor maker Intel (NASDAQ:INTC)
jumped 7% in the morning session after the stock's positive momentum continued as Nvidia acquired $5 billion in company shares through a private placement, while the U.S. Treasury also obtained a 10% non-voting equity stake.
Shares of memory chips maker Micron (NYSE:MU)
jumped 8.1% in the morning session after Bernstein SocGen Group raised its price target on the company to $330 from $270, citing strong demand for artificial intelligence applications.
Shares of data center products and services company Vertiv (NYSE:VRT)
jumped 8.5% in the morning session after Barclays upgraded the stock to 'Overweight' from 'Equal-Weight' and raised its price target, citing higher earnings estimates.
The Dow Jones Industrial Average began the 2026 trading year with a determined show of resilience, shaking off a late-December slump to post gains on the first trading day of the year. After a grueling four-session losing streak that dampened the spirits of investors during the final week of 2025,
Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 16.6% year on year to $70.45 million. The company expects the full year’s revenue to be around $1.05 billion, close to analysts’ estimates. Its non-GAAP loss of $1.25 per share was 10.5% below analysts’ consensus estimates.
Real estate developer Howard Hughes Holdings (NYSE:HHH) announced better-than-expected revenue in Q3 CY2025, with sales up 19.3% year on year to $390.2 million. Its GAAP profit of $2.02 per share was 32% above analysts’ consensus estimates.
As the curtain closes on 2025, the U.S. dollar is finishing the year on its back foot, marking a significant shift in the global macroeconomic landscape. After a multi-year period of dominance fueled by aggressive interest rate hikes and "U.S. exceptionalism," the U.S. Dollar Index (DXY) has
Shares of non-lethal weapons company Byrna (NASDAQ:BYRN)
jumped 7.1% in the afternoon session after investors reacted to technical indicators suggesting the stock was oversold and due for a rebound, a view supported by positive analyst sentiment. The move followed a period where the stock had declined 11.2% over the previous four weeks. This drop pushed a technical indicator known as the Relative Strength Index (RSI) to a reading of 29.16. An RSI below 30 is often interpreted by traders as a sign that a stock is oversold, meaning the selling pressure might have been exhausted and a price reversal could be near.
